Delfina Advances Maternal Health with $17M AI-Driven Initiative
Deal News | Jan 28, 2025 | USVP Management Co LLC
Delfina, aiming to transform maternal health with AI technology, has announced a successful Series A funding round of $17 million, spearheaded by US Venture Partners (USVP). The firm’s innovative AI-powered platform is designed to address the critical maternal health crisis in the United States, characterized by high maternal mortality rates and significant racial disparities in healthcare outcomes. Delfina's platform has demonstrated success in reducing preterm births, NICU admissions, and other pregnancy-related health issues, ensuring both improved outcomes and cost savings for healthcare plans. The latest funding will enable Delfina to expand its reach nationwide, further develop its predictive technology, and provide advanced support for underserved communities. New investors ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund, along with existing backers, highlight Delfina's role in driving innovation and equity in maternal care.
Sectors
- Healthcare Technology
- Venture Capital
Geography
- United States – The article discusses the maternal health crisis and innovation within the context of the United States.
Industry
- Healthcare Technology – Delfina uses AI-powered technology to innovate maternal healthcare, addressing significant health disparities.
- Venture Capital – US Venture Partners leads a significant investment in Delfina, emphasizing growth and innovation in healthcare.
Financials
- $17 million – Series A funding amount raised by Delfina.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Delfina | Target company | Company | An AI-powered maternal health platform focused on improving healthcare outcomes. |
| US Venture Partners (USVP) | Lead investor | Company | A venture capital firm leading the Series A funding round for Delfina. |
| HOPE Clinic | Healthcare provider | Company | A clinic utilizing Delfina's platform to improve maternal health outcomes. |
| Dr. Senan Ebrahim | Founder and CEO | Person | CEO of Delfina, leading efforts to transform maternal health through technology. |
| Dr. Fatimah Lalani | Chief Medical Officer | Person | CMO at HOPE Clinic, noting the benefits of Delfina's AI interventions. |
| ARTIS Ventures | New investor | Company | Investor in Delfina's Series A round. |
| Mayo Clinic | New investor | Company | Renowned medical organization investing in Delfina. |
| Tokio Marine Future Fund | New investor | Company | Part of the new investors in Delfina's funding round. |
| Story Ventures | Existing investor | Company | A continuing investor in Delfina. |
| SemperVirens | Existing investor | Company | An investor supporting Delfina's healthcare mission. |
| Bread and Butter Ventures | Existing investor | Company | Existing backers of Delfina's innovative platform. |
| Boutique Ventures | Existing investor | Company | Continues to support Delfina's efforts in maternal health. |
| Metrodora Ventures | Existing investor | Company | Chelsea Clinton's venture, supporting Delfina's growth. |